The report lists Biocon as a one-month-low breakdown stock, down 2.98%.
Read this note →Biocon Limited
NSE BIOCON BSE 532523 INE376G01013
0 filings · 0 analysed
368.50
-3.46%
over 1 year
-
Daily Derivatives Report 8 October 2026
The report lists Biocon as a one-month-low breakdown stock, down 2.98%.
-
The note lists Biocon among stocks showing weakness in the derivatives segment.
-
The report forecasts Biocon sales growth of 4.1% YoY but PAT growth of 54.1% YoY in 2QFY27.
Prices from Yahoo Finance, NSE close, delayed — indicative only, not for dealing. Solid markers sit on the exchange's own timestamp.
What the desks said
The note lists Biocon among stocks showing weakness in the derivatives segment.
Read this note →The report forecasts Biocon sales growth of 4.1% YoY but PAT growth of 54.1% YoY in 2QFY27.
Read this note →Announcement timeline
No filings stored for this company yet.
Never miss the next one.
Orivam emails what the research desks published each trading morning, attributed and linked to the original notes. Free.
Get the daily brief